Novel aspects for methodology and utilization of PET/CT imaging in head and neck cancer
| dc.contributor.author | Silvoniemi, Antti | |
| dc.contributor.department | fi=Kliininen laitos|en=Institute of Clinical Medicine| | - |
| dc.contributor.faculty | fi=Lääketieteellinen tiedekunta|en=Faculty of Medicine| | - |
| dc.contributor.studysubject | fi=Korva-, nenä- ja kurkkutautioppi|en=Otorhinolaryngology - Head and Neck Surgery| | - |
| dc.date.accessioned | 2018-04-05T11:41:20Z | |
| dc.date.available | 2018-04-05T11:41:20Z | |
| dc.date.issued | 2018-05-04 | |
| dc.description.abstract | Avainsanat: PET, PET/TT, pään ja kaulan alueen syöpä, [18F]EF5, [18F]FDG, hypoksia, molekulaarinen kuvantaminen, sädehoidon suunnittelu Positron emission tomography (PET), combined with computed tomography (CT),plays a key role in the management of head and neck cancer (HNC). In this thesis, novel aspects for PET/CT imaging of HNC regarding low oxygen levels, or hypoxia, and detection of glucose metabolism were evaluated. Hypoxia is a frequently observed hallmark of cancer contributing to radiotherapy resistance and poor prognosis. Enhanced glucose metabolism is characteristic of a malignant tumor, which is exploited in an everyday clinical application of [18F]FDG PET imaging. This study aimed to further investigate the feasibility of a novel hypoxia PET tracer [18F]EF5 and the potential of dynamic [18F]FDG PET/CT imaging in HNC. The first study indicated a favorable human biodistribution and radiation dosimetric profile of the hypoxia tracer [18F]EF5. The second preclinical study showed that the growth rate of human HNC xenografts in nude mice during the exponential growth period correlated with [18F]EF5 uptake in PET/CT images. In the third study, paired [18F]EF5 PET/CT scans performed for untreated HNC patients with a median time interval of seven days presented predominantly highly repeatable results. In the fourth study, advanced mathematical methodology for tracer uptake analysis was evaluated using dynamic [18F]FDG PET/CT in patients who were referred to chemoradiotherapy for oropharyngeal cancer. However, the method showed only a modest performance in the distinction of malignant, inflammatory and healthy tissues. In conclusion, further evaluation of [18F]EF5 PET/CT imaging and dynamic [18F]FDG PET/CT imaging seems important in the development of more effective strategies for the management of HNC. | - |
| dc.description.accessibilityfeature | ei tietoa saavutettavuudesta | |
| dc.format.content | fulltext | - |
| dc.identifier.olddbid | 161483 | |
| dc.identifier.oldhandle | 10024/144772 | |
| dc.identifier.uri | https://www.utupub.fi/handle/11111/26069 | |
| dc.identifier.urn | URN:ISBN:978-951-29-7186-2 | - |
| dc.language.iso | eng | - |
| dc.publisher | fi=Turun yliopisto|en=University of Turku| | - |
| dc.relation.ispartofseries | Turun yliopiston julkaisuja. Sarja D, Medica – Odontologica | - |
| dc.relation.issn | 2343-3213 | - |
| dc.relation.numberinseries | 1341 | - |
| dc.source.identifier | https://www.utupub.fi/handle/10024/144772 | |
| dc.title | Novel aspects for methodology and utilization of PET/CT imaging in head and neck cancer | - |
| dc.type.ontasot | fi=Artikkeliväitöskirja|en=Doctoral dissertation (article-based)| | - |
Tiedostot
1 - 1 / 1